United Kingdom Hemostats Market Size, Share, and COVID-19 Impact Analysis, By Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, and Others), By Formulation (Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, and Others), By Application (General Surgery, Orthopedic Surgery, Neurological Surgery, Cardiovascular Surgery, and Others), and UK Hemostats Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Hemostats Market Size Forecasts to 2035

• The United Kingdom Hemostats Market Size Was Estimated at USD 116.5 Million in 2024
• The UK Hemostats Market Size is Expected to Grow at a CAGR of around 7.27% from 2025 to 2035
• The UK Hemostats Market Size is Expected to Reach USD 252.2 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the UK Hemostats Market Size is anticipated to reach USD 252.2 Million by 2035, growing at a CAGR of 7.27% from 2025 to 2035. Hemostats are needed to control bleeding during complex surgeries, which has increased due to the rising incidence of chronic illnesses and the number of surgical procedures.

Market Overview

The UK hemostats market refers to surgical instruments to constrict tissues or blood vessels to stop bleeding. The hemostats market is benefiting from the ageing population, increased surgical procedures, and medical advancements. In multiple surgical procedures, including trauma and cardiovascular treatment, these tools are critical for blood loss mitigation and better outcomes.

The market is expanding as more complicated surgical procedures that require efficient intraoperative blood control are performed. Furthermore, new haemostatic agents of the next generation that offer improved safety, a lowered immunological reaction, and a quicker action have been developed as a result of developments in biomaterial science. Additionally, the market benefits from increased surgical professional awareness of enhanced haemostatic devices and training initiatives. Demand is also being increased by growing investments in healthcare infrastructure in emerging economies, which are making surgical care more accessible.

Report Coverage

This research report categorizes the market for the UK hemostats market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom hemostats market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom hemostats market.

Driving Factors

A growing number of surgical procedures, an ageing population, an increase in chronic diseases, and better access to healthcare in emerging nations are all driving the hemostats market's steady expansion. In a variety of specialties, hemostats are crucial for decreasing problems, improving precision, and controlling bleeding during procedures. The rise of the business is further supported by ongoing improvements in surgical methods and supplies. Hemostats are essential for enhancing patient care and guaranteeing successful surgical outcomes in light of the rising need for safe, effective surgical procedures.

Restraining Factors

Lack of health infrastructure, inadequate number of competent specialists, and financial constraints restrict access to haemostatic agents and devices. The delivery of these essential items to underserved and remote areas has been hampered by high costs, limited knowledge, and a poor supply chain. These factors hamper the hemostats market during the forecast period.

Market Segmentation

The United Kingdom hemostats market share is classified into type, formulation, and application.

• The oxidized regenerated cellulose-based hemostats segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom hemostats market is segmented by type into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, and others. Among these, the oxidized regenerated cellulose-based hemostats segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to their remarkable haemostatic qualities, which facilitate efficient coagulation and tissue repair, making them essential for a number of surgical operations. They have strengthened their market position due to their biocompatibility, biodegradability, and demonstrated safety in treating surgical bleeding problems.

• The matrix & gel hemostats segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom hemostats market is segmented by formulation into matrix & gel hemostats, sponge hemostats, powder hemostats, and others. Among these, the matrix & gel hemostats segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This expansion can be ascribed to hemostats' adaptability and simplicity of use, which make them appropriate for a range of surgical techniques.

• The orthopedic segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom hemostats market is segmented by application into general surgery, orthopedic surgery, neurological surgery, cardiovascular surgery, and others. Among these, the orthopedic segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is a result of the huge number of orthopaedic procedures carried out worldwide, such as spinal surgery, joint replacements, and sports injuries.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom hemostats market and a with comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Advanced Medical Solutions Group PLC
• Teleflex
• Integra LifeSciences
• Smith and Nephew
• C.R. Bard
• Hemostasis, Inc.
• Medtronic
• GrahamField Healthcare
• Baxter International
• CSL Behring
• Fresenius Kabi
• Stryker
• Johnson and Johnson
• Ethicon
• ZMedica
• Others

Recent Developments:

• In November 2023, Ethicon (Johnson & Johnson MedTech) introduced Ethizia, a haemostatic sealing patch authorised for use in European markets, including the UK.
• In April 2023, Olympus UK & Ireland expanded its endoscopic haemostasis product line throughout EMEA by launching the EndoClot line (Adhesive, Polysaccharide Haemostatic Spray, Submucosal Injection).

Key Target Audience

• Investors
• Market players
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom hemostats market based on the below-mentioned segments:

United Kingdom Hemostats Market, By Type

• Thrombin-Based Hemostats
• Oxidized Regenerated Cellulose-Based Hemostats
• Combination Hemostats
• Others

United Kingdom Hemostats Market, By Formulation

• Matrix & Gel Hemostats
• Sponge Hemostats
• Powder Hemostats
• Others

United Kingdom Hemostats Market, By Application

• General Surgery
• Orthopedic Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Others